SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-018095
Filing Date
2017-05-03
Accepted
2017-05-03 16:12:12
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 427021
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12403
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12495
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5211
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5317
  Complete submission text file 0001140361-17-018095.txt   2952494

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT edge-20170331.xml EX-101.INS 395244
7 XBRL TAXONOMY EXTENSION SCHEMA edge-20170331.xsd EX-101.SCH 31036
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20170331_cal.xml EX-101.CAL 34904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20170331_def.xml EX-101.DEF 146017
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20170331_lab.xml EX-101.LAB 509181
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20170331_pre.xml EX-101.PRE 261357
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 17809282
SIC: 2834 Pharmaceutical Preparations